These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33902384)

  • 1. Whole blood transfusion reduces overall component transfusion in cases of placenta accreta spectrum: a pilot program.
    Munoz JL; Kimura AM; Xenakis E; Jenkins DH; Braverman MA; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6455-6460. PubMed ID: 33902384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS).
    Munoz JL; Pfeiffer AF; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8640-8644. PubMed ID: 34657560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care for women with placenta accreta spectrum.
    Couret M; Huang Y; Khoury-Collado F; Friedman A; Hou JY; St Clair CM; Tergas AI; Ananth CV; Wright JD
    J Matern Fetal Neonatal Med; 2021 Oct; 34(20):3370-3376. PubMed ID: 31744356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open versus endovascular REBOA control of blood loss during cesarean delivery in the placenta accreta spectrum: A single-center retrospective case control study.
    Riazanova OV; Reva VA; Fox KA; Romanova LA; Kulemin ES; Riazanov AD; Ioscovich A
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():23-28. PubMed ID: 33388487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach to reduce blood loss in patients with placenta accreta spectrum disorder.
    Turan OM; Shannon A; Asoglu MR; Goetzinger KR
    J Matern Fetal Neonatal Med; 2021 Jul; 34(13):2061-2070. PubMed ID: 31455134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach.
    Shamshirsaz AA; Fox KA; Salmanian B; Diaz-Arrastia CR; Lee W; Baker BW; Ballas J; Chen Q; Van Veen TR; Javadian P; Sangi-Haghpeykar H; Zacharias N; Welty S; Cassady CI; Moaddab A; Popek EJ; Hui SK; Teruya J; Bandi V; Coburn M; Cunningham T; Martin SR; Belfort MA
    Am J Obstet Gynecol; 2015 Feb; 212(2):218.e1-9. PubMed ID: 25173187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.
    Sentilhes L; Seco A; Azria E; Beucher G; Bonnet MP; Branger B; Carbillon L; Chiesa C; Crenn-Hebert C; Dreyfus M; Dupont C; Fresson J; Huissoud C; Langer B; Morel O; Patrier S; Perrotin F; Raynal P; Rozenberg P; Rudigoz RC; Vendittelli F; Winer N; Deneux-Tharaux C; Kayem G;
    Am J Obstet Gynecol; 2022 Jun; 226(6):839.e1-839.e24. PubMed ID: 34914894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Matsuzaki S; Vestal NL; Sangara RN; Mandelbaum RS; Matsushima K; Klar M; Ouzounian JG
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2234-2243. PubMed ID: 34622939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of clinical outcomes with the application of the 2020 consensus panel on histological classification for Placenta Accreta Spectrum (PAS).
    Munoz JL; Pfeiffer AF; Ramsey PS
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10044-10048. PubMed ID: 35703727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.
    El Gelany S; Mosbeh MH; Ibrahim EM; Mohammed M; Khalifa EM; Abdelhakium AK; Yousef AM; Hassan H; Goma K; Alghany AA; Mohammed HF; Azmy AM; Ali WA; Abdelraheim AR
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):313. PubMed ID: 31455286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss.
    Seoud MA; Nasr R; Berjawi GA; Zaatari GS; Seoud TM; Shatila AS; Mirza FG
    J Neonatal Perinatal Med; 2017; 10(1):9-15. PubMed ID: 28304318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel transverse uterine incisions, a novel approach for managing heavy hemorrhage and preserving the uterus: A retrospective cohort study for patients with anterior placenta previa and accreta.
    Peng X; Chen D; Xu J; Liu X; You Y; Peng B
    Medicine (Baltimore); 2019 Nov; 98(44):e17742. PubMed ID: 31689824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy.
    Gatta LA; Weber JM; Gilner JB; Lee PS; Grotegut CA; Herbert KA; Bashir M; Pieper CF; Ronald J; Pabon-Ramos W; Habib AS; Strickland KC; Secord AA; James AH
    Am J Perinatol; 2022 Oct; 29(14):1503-1513. PubMed ID: 35973741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta accreta spectrum: We can do better.
    Silveira C; Kirby A; Melov SJ; Nayyar R
    Aust N Z J Obstet Gynaecol; 2022 Jun; 62(3):376-382. PubMed ID: 34984671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 20. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique.
    Palacios-Jaraquemada JM; Fiorillo A; Hamer J; Martínez M; Bruno C
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):275-282. PubMed ID: 31984808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.